Saturday, July 11, 2026

pharma · Hepatocellular Carcinoma · Obesity

Hospital Authority

Hospital Authority, Hong is a pharma organization headquartered in CN. Primary therapeutic focus areas include Hepatocellular Carcinoma, Obesity, Acute Kidney Injury, Nasopharyngeal Carcinoma, Coronary Artery Disease. No

Hospital Authority Building, 147B Argyle Street, Kowloon, Hong Kong, 852, HK, CN HQ
1991 Founded
12,669 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Hospital Authority Building, 147B Argyle Street, Kowloon, Hong Kong, 852, HK, CN
Founded
1991
Employees
12,669
Programs
322
Drugs
301
Patents
0
Clinical program

Ferrous Fumarate Oral Tablet

Unknown · small molecule · Iron Deficiency Anemia Treatment

Ferrous Fumarate Oral Tablet for Iron Deficiency Anemia Treatment is a Unknown program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Internal code Hemato-001

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Hospital Authority, Hong Kong
Phase
Unknown
Modality
small_molecule
Indication
Iron Deficiency Anemia Treatment
Status
active
Trials
1